FDA
Loteprednol Etabonate
The FDA lists this product in 13 strengths and forms.
Composition
- Active ingredients
- LOTEPREDNOL ETABONATE 0.5%
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LOTEPREDNOL ETABONATE 0.5% · GelThis page
- LOTEPREDNOL ETABONATE 0.2% · Suspension/dropsANDA216345-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · GelANDA212080-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · Suspension/dropsANDA215719-001 · Prescription
- LOTEPREDNOL ETABONATE 0.2% · Suspension/dropsANDA215203-001 · Prescription
- LOTEPREDNOL ETABONATE 0.38% · GelANDA218087-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · Suspension/dropsANDA212450-001 · Prescription
- LOTEPREDNOL ETABONATE 0.2% · Suspension/dropsANDA215933-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · Suspension/dropsANDA207609-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · Suspension/dropsANDA215204-001 · Prescription
- LOTEPREDNOL ETABONATE 0.5% · Suspension/dropsANDA217484-001 · Prescription
At a glance
- Brand name
- Loteprednol Etabonate
- Route
- Eye
- Dosage form
- Gel
- Applicant
- Hikma
- Status
- Discontinued
- FDA approval
- 29 Nov 2023
- Application
- ANDA213956-001
- RxCUI
- 52177